External Beam Radiation Therapy (EBRT) for Patients with Malignant Pheochromocytoma and Non-Head and -Neck Paraganglioma: Combination with 131I-MIBG
- 7 May 2012
- journal article
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 44 (05), 405-410
- https://doi.org/10.1055/s-0032-1308992
Abstract
In patients with malignant pheochromocytoma and paraganglioma, 131I-MIBG radiotherapy can achieve an objective response rate of 30–50% with the dose limiting toxicity being hematologic. Patients with disseminated disease, who also have a few index bulky or symptomatic lesions, may benefit from the addition of targeted external beam radiotherapy alone or in combination with systemic 131I-MIBG. The records of patients with malignant paraganglioma who were treated with external beam radiotherapy at the University of Pennsylvania from February 1973 to February 2011 were reviewed in an institutional review board approved retrospective study. Of the 17 patients with tumors in the thorax, abdomen, or pelvis, 76% had local control or clinically significant symptomatic relief for at least 1 year or until death. As expected, the predominant toxicity was due to irradiation of tumor-adjacent normal tissues without clinically significant hematologic toxicity. Due to widespread systemic metastases with areas of bulky, symptomatic tumor, 5 of the 17 patients were treated with sequential 131I-MIBG (2 mCi/kg per treatment) and external beam radiotherapy to 9 sites. In these patients, all areas that were irradiated with external beam radiotherapy showed durable objective response despite all patients eventually experiencing out-of-field systemic progression requiring other treatment. Four of these patients remain alive with excellent performance status 16, 18, 23, and 24 months after external beam radiotherapy. External beam radiotherapy can be highly effective in local management of malignant paraganglioma and can be used in conjunction with 131I-MIBG due to nonoverlapping toxicities with excellent control of locally bulky tumors.Keywords
This publication has 15 references indexed in Scilit:
- Targeted Systemic Radiotherapy of Pheochromocytoma and Medullary Thyroid CancerSeminars in Nuclear Medicine, 2011
- Paraganglioma of the Head and NeckAmerican Journal of Clinical Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- Pheochromocytoma of the urinary bladder: report of 2 cases and review of literature.2008
- Long-term results of irradiation for paragangliomaInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Recurrent head-and-neck chemodectomas: a comparison of surgical and radiotherapeutic resultsInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Radiation Therapy of Metastatic Pheochromocytoma: Case Report and Review of the LiteratureAmerican Journal of Clinical Oncology, 1996
- Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- High-voltage irradiation and combination chemotherapy for malignant pheochromocytomaCancer, 1988
- Chemodectomas of the neck: the response to radiotherapyBritish Journal of Surgery, 1985